← Back to Search

EQUIPED-ADRD Intervention for Dementia (EQUIPED-ADRD Trial)

N/A

Waitlist Available

Led By Joshua Chodosh, MD, MSHS, FACP

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to month 24

Awards & highlights

EQUIPED-ADRD Trial Summary

This trial will develop and test an intervention to improve care quality for patients with Alzheimer's disease and related dementia who also have diabetes. The intervention will feature use of consensus decisional guidance for the medical management of diabetes, provider workflow enhancements supported by a panel manager, electronic health record decision support and feedback, and PCP collaborative learning.

Eligible Conditions

Dementia
Diabetes
Alzheimer's Disease

EQUIPED-ADRD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to month 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to month 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to month 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of Patients Who Reach Consensus Target HBA1c

EQUIPED-ADRD Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Intervention (INT)Experimental Treatment1 Intervention

(10 clinic sites and ~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM)

Group II: Control (CON)Placebo Group1 Intervention

During training the CON providers will be encouraged to do cognitive screening as well as follow the guidelines in general.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

EQUIPED-ADRD Intervention

2018

N/A

~360

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

839,366 Total Patients Enrolled

16 Trials studying Dementia

66,739 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,004,759 Total Patients Enrolled

265 Trials studying Dementia

23,623,056 Patients Enrolled for Dementia

Joshua Chodosh, MD, MSHS, FACPPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is participation in this research endeavor being facilitated?

"Correct. According to the clinicaltrials.gov listing, this medical research was initially posted on December 3rd 2018 and has been actively recruiting ever since its most recent amendment dated June 20th 2022. 1000 patients are required for enrollment at a single location."

Answered by AI

Is there any availability for participants in this research endeavor?

"As indicated on clinicaltrials.gov, the enrollment period for this medical experiment is ongoing. The trial was first advertised on December 3rd 2018 and has since been updated as recently as June 20th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhanced Quality in Primary Care for Elders With Diabetes and Dementia

2018. "Enhanced Quality in Primary Care for Elders With Diabetes and Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03723707.